Cargando…
Gender differences in diet-induced steatotic disease in Cyp2b-null mice
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease; however, progression to nonalcoholic steatohepatitis (NASH) is associated with most adverse outcomes. CYP2B metabolizes multiple xeno- and endobiotics, and male Cyp2b-null mice are diet-induced obese (DIO) with increased NAFL...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064244/ https://www.ncbi.nlm.nih.gov/pubmed/32155178 http://dx.doi.org/10.1371/journal.pone.0229896 |
_version_ | 1783504844743507968 |
---|---|
author | Heintz, Melissa M. McRee, Rebecca Kumar, Ramiya Baldwin, William S. |
author_facet | Heintz, Melissa M. McRee, Rebecca Kumar, Ramiya Baldwin, William S. |
author_sort | Heintz, Melissa M. |
collection | PubMed |
description | Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease; however, progression to nonalcoholic steatohepatitis (NASH) is associated with most adverse outcomes. CYP2B metabolizes multiple xeno- and endobiotics, and male Cyp2b-null mice are diet-induced obese (DIO) with increased NAFLD. However, the DIO study was not performed long enough to assess progression to NASH. Therefore, to assess the role of Cyp2b in fatty liver disease progression from NAFLD to NASH, we treated wildtype (WT) and Cyp2b-null mice with a normal diet (ND) or choline-deficient, L-amino acid-defined high fat diet (CDAHFD) for 8 weeks and determined metabolic and molecular changes. CDAHFD-fed WT female mice gained more weight and had greater liver and white adipose tissue mass than their Cyp2b-null counterparts; males experienced diet-induced weight loss regardless of genotype. Serum biomarkers of liver injury increased in both CDAHFD-fed female and male mice; however CDAHFD-fed Cyp2b-null females exhibited significantly lower serum ALT, AST, and ASP concentrations compared to WT mice, indicating Cyp2b-null females were protected from liver injury. In both genders, hierarchical clustering of RNA-seq data demonstrates several gene ontologies responded differently in CDAHFD-fed Cyp2b-null mice compared to WT mice (lipid metabolism > fibrosis > inflammation). Oil Red O staining and direct triglycerides measurements confirmed that CDAHFD-fed Cyp2b-null females were protected from NAFLD. CDAHFD-fed Cyp2b-null mice showed equivocal changes in fibrosis with transcriptomic and serum markers suggesting less inflammation due to glucocorticoid-mediated repression of immune responses. In contrast to females, CDAHFD-fed Cyp2b-null males had higher triglyceride levels. Results indicate that female Cyp2b-null mice are protected from NAFLD while male Cyp2b-null mice are more susceptible to NAFLD, with few significant changes in NASH development. This study confirms that increased NAFLD development does not necessarily lead to progressive NASH. Furthermore, it indicates a role for Cyp2b in fatty liver disease that differs based on gender. |
format | Online Article Text |
id | pubmed-7064244 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-70642442020-03-23 Gender differences in diet-induced steatotic disease in Cyp2b-null mice Heintz, Melissa M. McRee, Rebecca Kumar, Ramiya Baldwin, William S. PLoS One Research Article Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease; however, progression to nonalcoholic steatohepatitis (NASH) is associated with most adverse outcomes. CYP2B metabolizes multiple xeno- and endobiotics, and male Cyp2b-null mice are diet-induced obese (DIO) with increased NAFLD. However, the DIO study was not performed long enough to assess progression to NASH. Therefore, to assess the role of Cyp2b in fatty liver disease progression from NAFLD to NASH, we treated wildtype (WT) and Cyp2b-null mice with a normal diet (ND) or choline-deficient, L-amino acid-defined high fat diet (CDAHFD) for 8 weeks and determined metabolic and molecular changes. CDAHFD-fed WT female mice gained more weight and had greater liver and white adipose tissue mass than their Cyp2b-null counterparts; males experienced diet-induced weight loss regardless of genotype. Serum biomarkers of liver injury increased in both CDAHFD-fed female and male mice; however CDAHFD-fed Cyp2b-null females exhibited significantly lower serum ALT, AST, and ASP concentrations compared to WT mice, indicating Cyp2b-null females were protected from liver injury. In both genders, hierarchical clustering of RNA-seq data demonstrates several gene ontologies responded differently in CDAHFD-fed Cyp2b-null mice compared to WT mice (lipid metabolism > fibrosis > inflammation). Oil Red O staining and direct triglycerides measurements confirmed that CDAHFD-fed Cyp2b-null females were protected from NAFLD. CDAHFD-fed Cyp2b-null mice showed equivocal changes in fibrosis with transcriptomic and serum markers suggesting less inflammation due to glucocorticoid-mediated repression of immune responses. In contrast to females, CDAHFD-fed Cyp2b-null males had higher triglyceride levels. Results indicate that female Cyp2b-null mice are protected from NAFLD while male Cyp2b-null mice are more susceptible to NAFLD, with few significant changes in NASH development. This study confirms that increased NAFLD development does not necessarily lead to progressive NASH. Furthermore, it indicates a role for Cyp2b in fatty liver disease that differs based on gender. Public Library of Science 2020-03-10 /pmc/articles/PMC7064244/ /pubmed/32155178 http://dx.doi.org/10.1371/journal.pone.0229896 Text en © 2020 Heintz et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Heintz, Melissa M. McRee, Rebecca Kumar, Ramiya Baldwin, William S. Gender differences in diet-induced steatotic disease in Cyp2b-null mice |
title | Gender differences in diet-induced steatotic disease in Cyp2b-null mice |
title_full | Gender differences in diet-induced steatotic disease in Cyp2b-null mice |
title_fullStr | Gender differences in diet-induced steatotic disease in Cyp2b-null mice |
title_full_unstemmed | Gender differences in diet-induced steatotic disease in Cyp2b-null mice |
title_short | Gender differences in diet-induced steatotic disease in Cyp2b-null mice |
title_sort | gender differences in diet-induced steatotic disease in cyp2b-null mice |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064244/ https://www.ncbi.nlm.nih.gov/pubmed/32155178 http://dx.doi.org/10.1371/journal.pone.0229896 |
work_keys_str_mv | AT heintzmelissam genderdifferencesindietinducedsteatoticdiseaseincyp2bnullmice AT mcreerebecca genderdifferencesindietinducedsteatoticdiseaseincyp2bnullmice AT kumarramiya genderdifferencesindietinducedsteatoticdiseaseincyp2bnullmice AT baldwinwilliams genderdifferencesindietinducedsteatoticdiseaseincyp2bnullmice |